CD19 and immunoglobulin G4-related sclerosing disease: Interestingly, we found a remarkable increase in the expression of a particular B-cell subset, which was characterized with CD19 + CD24-CD38hi surface markers in peripheral B cells from IgG4-RD patients; this B-cell subset was expressed at fairly low levels in pSS and HC.